JAK 2

1. What is it? Any common name for this procedure?

JAK2 (Janus Kinase 2) is a gene that provides instructions for making a protein that promotes the growth and division of cells. A JAK2 mutation test is a specialized blood or bone marrow test used to identify a specific change in this gene—most commonly the V617F mutation.

When this gene is mutated, it acts like a "broken switch" that is permanently turned on, causing the bone marrow to produce too many blood cells (red cells, white cells, or platelets).

Common Names:

• JAK2 V617F Mutation Analysis
• JAK2 Exon 12 Mutation Testing (a less common variant)
• Myeloproliferative Neoplasm (MPN) Panel
• JAK2 Quantitative PCR

2. Common Symptoms: When to Meet a Doctor

Most patients are referred for JAK2 testing because a routine blood test (Complete Blood Count) shows abnormally high levels of blood cells. You should consult a hematologist if you experience:

• Frequent Headaches or Dizziness: Caused by "thick" blood slowing down circulation.
• Itching (Pruritus): Especially after a warm bath or shower (common in Polycythemia Vera).
• Splenomegaly: A feeling of fullness or pain in the upper left abdomen due to an enlarged spleen.
• Unusual Blood Clots: Such as deep vein thrombosis (DVT) or a stroke at a young age.
• Erythromelalgia: Burning pain, redness, and swelling in the hands or feet.
• Night Sweats and Weight Loss: General signs of bone marrow overactivity.

3. List of Associated Diseases

The JAK2 mutation is a "hallmark" of a group of blood cancers known as Myeloproliferative Neoplasms (MPNs):

• Polycythemia Vera (PV): Over $95\%$ of patients with PV have a JAK2 mutation.
• Essential Thrombocythemia (ET): About $50\text{--}60\%$ of patients are JAK2 positive.
• Primary Myelofibrosis (PMF): About $50\text{--}60\%$ of patients carry the mutation.
• Budd-Chiari Syndrome: A rare condition where blood clots block the veins of the liver, often linked to an underlying JAK2 mutation.

4. List of Screening Tests

Testing for JAK2 is highly accurate and usually involves molecular techniques:

• Peripheral Blood Test: A standard blood draw from the arm is usually sufficient to detect the mutation.
• Bone Marrow Aspiration/Biopsy: If the blood test is positive, a doctor may sample the bone marrow to see how the mutation is affecting cell production.
• Quantitative PCR (qPCR): Measures the "allele burden" (what percentage of your cells carry the mutation).
• Next-Generation Sequencing (NGS): A more comprehensive test that looks for JAK2 alongside other mutations (like CALR or MPL) to provide a full genetic profile.

5. Am I Eligible for this Procedure?

You are a candidate for JAK2 testing if:

1. Elevated Blood Counts: Your CBC shows a persistently high Hemoglobin ($>16.5$ g/dL in men, $>16.0$ g/dL in women) or Platelet count ($>450,000/\mu$L).
2. Unexplained Clotting: You have had a "weird" blood clot (like in the gut or liver veins) without other risk factors.
3. Low Erythropoietin (EPO): If your EPO hormone levels are low but your red cell count is high, JAK2 testing is the next logical step.

6. Pre and Post Care

Pre-Care:

• No Special Prep: You do not need to fast for a JAK2 blood test.
• Medication Check: Inform your doctor if you have had a recent blood transfusion, as it might temporarily dilute the mutated cells in your sample.

Post-Care:

• Interpretation: A positive result means you likely have an MPN. This is a chronic condition, but it is not an immediate "death sentence"; many patients live for decades with proper treatment.
• Follow-up: If positive, you will likely start medications (like aspirin, hydroxyurea, or JAK inhibitors) to reduce the risk of clots.
• Monitoring: You will need regular blood tests to monitor your "allele burden" and blood cell counts.

7. Days Required for Hospitalization

• Blood Test Time: 5 to 10 minutes for the draw.
• Result Turnaround: Typically 5 to 10 working days (genetic testing takes time).
• Hospitalization: 0 Days (It is an outpatient procedure).

8. Benefits of JAK2 Testing

• Definitive Diagnosis: It provides a clear answer for why your blood counts are high, avoiding unnecessary other tests.
• Stroke/Heart Attack Prevention: By diagnosing the condition early, doctors can thin your blood and prevent life-threatening clots.
• Targeted Therapy: If you are JAK2 positive, you may be eligible for specific drugs called JAK inhibitors (like Ruxolitinib) that target the "broken switch" directly.
• Risk Stratification: Helps your doctor predict if your condition is likely to progress to a more serious stage, such as leukemia, allowing for closer monitoring.